Scorpion sting syndrome in a general hospital in Saudi Arabia

Saudi Medical Journal

Volumn 25, Issue 1, 2004, Pages 64-70

  Al Asmari, Abdulrahman K ^a   Al Saif, Abdulaziz A ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CHLORPHENIRAMINE; CHLORPROMAZINE; DIAZEPAM; DICLOFENAC; DOBUTAMINE; FUROSEMIDE; HYDRALAZINE; HYDROCORTISONE; ICE; LABETALOL; LIDOCAINE; LOCAL ANESTHETIC AGENT; LORAZEPAM; NIFEDIPINE; NORADRENALIN; PARACETAMOL; PENTOBARBITAL; PRAZOSIN; TOTAL; VENOM ANTISERUM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANALGESIA; ARTICLE; BITES AND STINGS; CHILD; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DEATH; DISEASE PREDISPOSITION; DRUG EFFICACY; EMERGENCY WARD; ENVENOMATION; FEMALE; GENERAL HOSPITAL; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; HYPERSALIVATION; HYPERTENSION; INCIDENCE; INFANT; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; PAIN; SAUDI ARABIA; SCORPION; SEASONAL VARIATION; SEX RATIO; SUMMER; SWEAT GLAND DISEASE; SYMPTOMATOLOGY; TACHYCARDIA; TOXICITY; WINTER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANIMALS; ANTIVENINS; ARACHNIDISM; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, GENERAL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PREVALENCE; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAUDI ARABIA; SCORPIONS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SYNDROME;

EID: 1342332101     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Fukuhara YDM, Reis ML, Dellalibera-Joviliano R, Cunha FQC, Donadi EA. Increased plasma levels of IL-1β, IL-6, IL-8, IL-10, and TNF-α in patients moderately or severely envenomed by Tityus serrulatus scorpion sting. Toxicon 2003; 41: 49-55.
2. Gajre G, Dammas AS. Scorpion envenomation in children: Should all stings be given antivenom? Annals of Saudi Medicine 1999; 19: 444-446.
3. Gueron M, Stern J, Cohen W. Severe myocardial damage and heart failure in scorpion sting. Am J Cardiol 1967; 19: 719-725.
4. Santhakrishnan BR, Gajalakshmi BS. Pathogenesis of cardiovascular complications in children following scorpion envenoming. Ann Trop Paediat 1986; 6: 117-121.
5. El-Amin EO, Elidrissy A, Hamid HS, Sultan OM, Safar R. Scorpion sting: a management problem. Ann Trop Paediat 1991; ll: 143-148.
6. Warrell DA. Venomous bites and stings in Saudi Arabia. Saudi Med J 1993; 14: 196-202.
7. Al-Sadoon MK, Jarrar BM. Epidemiological study of scorpion stings in Saudi Arabia between 1993 and 1997. J Venom Anim Toxins 2003; 9: 54-64.
8. Hisham M, Sherif E. Scorpion sting, is it a health problem in Saudi Arabia? Evaluation of management of 820 cases. Saudi Med J 1996; 17: 315-321.
9. Vachon M. Arachnids of Saudi Arabia. Scorpions. Fauna of Saudi Arabia 1979; 1: 30-65.
10. Al-Sadoon MK, Jarrar BM. A study of the frequency and incidence of scorpion stings and snakebites in Riyadh city. Journal of King Saud University, Science 1994; 2: 217-266.
11. Al-Sadoon MK, Al-Farraj SA. Scorpions of Saudi Arabia. Riyadh (KSA): Al-Jeraisy; 2000. p. 131.
12. Zlotkin E, Miranda F, Rochat H. Chemistry and pharmacology of Buthidae scorpion venoms. In: Bettini S, editor. Handbook of experimental pharmacology: Arthropod venoms. Berlin: Springer; 1978. p. 317-369.
13. Watt DD, Simard JM. Neurotxic proteins in scorpion venom. J Toxicol-Toxin Reviews 1984; 3: 181-221.
14. Gueron M, Adolph R, Grupp I, Groupp O, Gabel M, Flower NO. Hemodynamic and myocardial consequences of scorpion venom. Am J Cardiol 1980; 45: 979-986.
15. Freire-Maia L, Matos IM. Heparin or PAF antagonist (BN-5221) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in rats. Toxicon 1993: 31: 1207-1210.
16. Amaral CFS, Barbosa AJA, Leite VHR, Tafuri WL, Rezende NA. Scorpion sting-induced pulmonary edema: evidence of increased alveolo-capillary membrane permeability. Toxicon 1994; 32: 999-1003.
17. Teixeira CFP, Galante F, Manzoli S, Steil AA, Jancar S. Inflammatory reaction induced by Tityus serrulatus crude venom (TsV) in the lung of rats. SBTx- Reports. J Venom Anim Toxins 1997; 3: 111.
18. Ferreira LA, Zingalli R, Habermehl G, Lebrun I. Isolation and properties of a new kallikrein inhibitor from Tityus serrulatus venom. J Protein Chem 1998; 17: 799-805.
19. Meki AAM, Mohamed ZMM, Mohey El-deen HM. Significance of assessment of serum cardiac troponin I and interleukin-8 in scorpion envenomed children. Toxicon 2003; 41: 129-137.
20. Gueron M, Margulis G, Ilia R, Sofer S. The management of scorpion envenomation. A review. Toxicon 1993; 31: 1071-1076.
21. Gueron M, Ilia R, Sofer S. The cardiovascular system after scorpion envenomation. A review. J Toxic Clinic Toxic 1992; 30: 245-258.
22. Yarom R. Scorpion venom: a tutorial review of its effects in men and experimental animals. Clin Toxicol 1970; 3: 561-569.
23. Bawaskar HS, Bawaskar PH. Treatment of cardiovascular manifestation of human scorpion envenoming: is serotherapy essential? J Trop Med Hyg 1991; 94: 156-158.
24. Bawaskar HS, Bawaskar PH. Role of atropine in management of cardiovascular manifestations of scorpion envenomation in humans. J Trop Med Hyg 1992a; 95: 30-35.
25. Bawaskar HS, Bawaskar PH. Management of cardiovascular manifestation of poisoning by the Indian red scorpion. Br Heart J 1992b; 68: 478-480.
26. Ismail M, Fatani AJY, Dabees TT. Experimental treatment protocols for scorpion envenomation: a review of common therapies and effect of kallikrein-kinin inhibitors. Toxicon 1992; 30: 1257-1279.
27. Kankonkar RC, Murthy KR, Zare A, Malathi A, Blasabramaniam P, Yeolekar ME. Reversal of cardiovascular and haemodynamic disturbances by scorpion antivenom administration in myocarditis due to envenomation by Indian red scorpion (Buthidae family) venom. Abstracts of the 10th. World Congress on Animal, Plant and Microbial Toxins. Toxicon 1992; 30: 523.
28. Radha Krishna Murthy K, Kankonkar RC, Zare AM, Malthi A, Balasubramaniam P, Yeolekar ME. Reversal of metabolic and electrocardiographic changes by scorpion antivenom administration in experimental myocarditis by Indian red scorpion (Buthidae family) venom. Abstracts of the 10th. World Congress on Animal, Plant and Microbial Toxins. Toxicon 1992; 30: 545.
29. Moss J, Kesic T, Henry DP, Kopin IJ. Scorpion venom-induced discharge of catecholamines accompanied by hypertension. Brain Res 1973; 54: 381-385.
30. Moss J, Thoa NB, Kopin IJ. On the mechanism of scorpion-induced release of norepinephrine. J Exp Ther 1974; 90: 39-48.
31. Gueron M, Weizman S. Catecholamine and myocardial damage in scorpion sting. Am Heart J 1968; 75: 716-717.
32. Gueron M, Weizman S. Catecholamine excretion in scorpion sting. Isr J Med Sci 1969; 5: 855-857.
33. Gueron M, Yarom R. Cardiovascular manifestations of severe scorpion sting. First J Med Sci 1969; 5: 855-857.
34. Cantor A, Waderman KL, Ovsyshcher I, Gueron M. Parasympathomimetic action of scorpion venom on the cardiovascular system. Isr J Med Sci 1977; 13: 9-13.
35. Ismail M, El Asmar AF, Osman OH. Pharmacological studies with scorpion venom: evidence for the presence of histamine. Toxicon 1975; 13: 49-56.
36. Neale JR. Scorpion sting syndrome in eastern Riyadh. Annals of Saudi Medicine 1990; 10: 383-388.
37. Ismail M. The scorpion envenoming syndrome. Toxicon 1995; 33: 825-858.
38. Schweitz H, Bidard JN, Maes P, Lazdunski M. Charybdotoxin is a new member of the K+ channel toxin family that includes dendrotoxin I and mast cell degranulating peptide. Biochem 1989; 28: 9708-9714.
39. Makinnon R, Heginbotham L, Abramson T. Mapping the receptor site of charybdotoxin, a pore-blocking potassium channel inhibitor. Neuron 1990; 5: 767-771.
40. DeBin JA, Maggio JE, Stricharz GR. Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am J Physiol 1993; 264: C361-C369.
41. Garcia ML, Galvez A, Garcia Calvo M, King VF, Vazquez J, Akczorowski GJ. Use of the toxins to study the potassium channels. J Bioenerg Biomemb 1991; 23: 615-646.
42. Valdivia HH, Kirby MS, Lederer WJ, Coronado R. Scorpion toxins targeted against the sarcoplasmic reticulum Ca2+ release channel of skeletal and cardiac muscle. Proc Natl Acad Sci U S A 1992; 89: 1285-1289.
43. Gehlert DR, Gackenheimer SL, Robertson DW. Autoradiographic localization of (125I) charybdotoxin binding sites in rat brain. Neurosci Lett 1992; 140: 25-29.
44. Sofer S, Cohen R, Shapir Y, Chen L, Colon A, Scharf SM. Scorpion venom leads to gastrointestinal ischemia. Crit Care Med 1997; 25: 834-840.
45. Dittrich K, Power AP, Smith NA. Scorpion sting syndrome - a ten-year experience. Annals of Saudi Medicine 1995; 15: 148-155.
46. Ismail M, Osman OH, Ibraheem SA, El-Asmar MF. Cardiovascular and respiratory responses to the venom from the scorpion Leiurus quinquestriatus. East Afr Med J 1972; 49: 274-281.
47. Rachesky IJ, Banner W, Dansky J, Tong T. Treatments for Centruroides exilicauda envenomation. AJDC 1984; 138: 1136-1139.
48. Ghazal A, Ismail M, Abdel-Rahman AA, El-Asmar MF. Pharmacological studies of scorpion (Androctonus amoreuxi Aud & Sav) venom. Toxicon 1975; 13: 253-259.
49. Ismail M, Osman OH, Gumaa KA, Karrar MA. Pharmacological studies with scorpions (Pandinus exitialis) venom. Toxicon 1974; 12: 75-82.
50. Karnard DR. Hemodynamic patterns in patients with scorpion envenomation. Heart 1998; 79: 485-489.
51. Gueron M, Margulis G, Sofer S. Echocardiographic and radionuclide angiographic observations following scorpion envenomation by Leiurus quinquestriatus. Toxicon 1990; 28: 1005-1009.
52. Gueron M, Ilia R, Shahak E, Sofer S. Renin and aldosterone levels and hypertension following envenomation in humans by the yellow scorpion Leiurus quinquestriatus. Toxicon 1992; 30: 765-767.
53. Andrade MV, Souza DG, de A Castro MS, Cunha-Melo JR, Teixeira MM. Evidence for a role of capsaicin-sensitive sensory nerves in the lung oedema induced by Tityus serrulatus venom in rats. Toxicon 2002; 40: 283-287.
54. Silveira NP, Moraes-Santos T, Azevedo AD, Freire-Maia L. Effects of Tityus serrulatus scorpion venom and one of its purified toxins (toxin alpha) on the isolated guinea pig heart. Comb Biochem Biophys 1991; 18: 329-335.
55. Bawasker HS, Bawasker PH. Scorpion envenoming and the cardiovascular system. Trop Doc 1997; 27: 6-9.
56. Freire-Maia L, Campos JA. Response to the letter by Gueron and Ousysoysben on the treatment of the cardiovascular manifestations of scorpion envenomation. Toxicon 1987; 25: 33-56.
57. Gueron M, Ovsyshcher I. What is the treatment for the cardiovascular manifestations of scorpion envenomation? Toxicon 1987; 25: 121-124.
58. World Health Organization. Progress in the characterization of venoms and standardization of antivenoms. Geneva: WHO; 1981.
59. Fatani AJ. Some pharmacological studies of the cardiovascular and related effects of scorpion envenoming: the setting up as an experimental treatment protocol. Proposal for the MSc. [dissertation]. Riyadh (KSA): King Saud University; 1987.
60. Ministry of Health. Protocol for the treatment of scorpion envenoming in Saudi Arabia. Epidemic diseases department. MOH 1999. Riyadh (KSA): Ministry of Health; 1999.
61. Sofer S, Shahak E, and Gueron M. Scorpion envenomation and antivenom therapy. J Paediatr 1994; 124: 973-978.